Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Albanese

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
CNS Drugs|October 26, 2019
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple SclerosisCarolina Gabri Nicoletti, Doriana Landi, Fabrizia Monteleone, et al.
The Journal of Headache and Pain|April 10, 2022
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Headache|July 26, 2021
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 studyPiero Barbanti, Cinzia Aurilia, Sabina Cevoli, et al.
Epilepsia|January 28, 2016
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulationAndrea Romigi, Maria Albanese, Fabio Placidi, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control StudyMaria Albanese, Giulia Marrone, Agostino Paolino, et al.
JAMA Neurology|October 17, 2014
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer diseaseClaudio Liguori, Andrea Romigi, Marzia Nuccetelli, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patientsAnnalisa Noce, Maria Albanese, Giulia Marrone, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 25, 2019
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recordingDomenico G Della Rocca, Maria Albanese, Fabio Placidi, et al.
The Journal of Headache and Pain|May 26, 2020
Persistent post-traumatic headache: a migrainous loop or not? The clinical evidenceAlejandro Labastida-Ramírez, Silvia Benemei, Maria Albanese, et al.
Brain, Behavior, and Immunity|December 22, 2022
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunctionTommaso Schirinzi, Roberta Lattanzi, Daniela Maftei, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
CNS Drugs|October 26, 2019
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple SclerosisCarolina Gabri Nicoletti, Doriana Landi, Fabrizia Monteleone, et al.
The Journal of Headache and Pain|April 10, 2022
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Headache|July 26, 2021
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 studyPiero Barbanti, Cinzia Aurilia, Sabina Cevoli, et al.
Epilepsia|January 28, 2016
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulationAndrea Romigi, Maria Albanese, Fabio Placidi, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control StudyMaria Albanese, Giulia Marrone, Agostino Paolino, et al.
JAMA Neurology|October 17, 2014
Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer diseaseClaudio Liguori, Andrea Romigi, Marzia Nuccetelli, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patientsAnnalisa Noce, Maria Albanese, Giulia Marrone, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|October 25, 2019
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recordingDomenico G Della Rocca, Maria Albanese, Fabio Placidi, et al.
The Journal of Headache and Pain|May 26, 2020
Persistent post-traumatic headache: a migrainous loop or not? The clinical evidenceAlejandro Labastida-Ramírez, Silvia Benemei, Maria Albanese, et al.
Brain, Behavior, and Immunity|December 22, 2022
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunctionTommaso Schirinzi, Roberta Lattanzi, Daniela Maftei, et al.
Pageof 9